Skip to Content


Filter by:



Second Opinion

Learn about policy issues important to medical schools and teaching hospitals, with Executive Vice President Atul Grover, M.D., Ph.D.

Research

Future innovations in health care and prevention require research across a full spectrum of biomedical science, from basic and translational research to implementation science and comparative effectiveness research. 

AAMC advocates for funding and appropriate regulation by major federal agencies and organizations supporting this research, including the National Institutes of Health (NIH), Agency for Healthcare Research and Quality (AHRQ), and the Department of Veterans Affairs (VA).

Ensuring a sustainable research mission is essential to achieve long-term health priorities, develop new therapeutics and preventive measures, focus on patient-centered outcomes, and reduce health disparities. 

We also work to ensure the integrity of biomedical research, especially research involving human subjects, including privacy protections and management of financial conflicts of interest.

Related

Responsible Conduct of Research
Research with AnimalsStem Cell Research and Regenerative Medicine

News and Updates


OMB Provides Guidance on Executive Order on Reducing Regulation and Controlling Costs

April 21, 2017

The Office of Management and Budget’s (OMB) Office of Information and Regulatory Affairs (OIRA) April 5 released guidance on the requirements of the Jan. 30 Executive Order (EO), “Reducing Regulation and Controlling Regulatory Costs.” The new guidance supplements the Feb. 2 interim guidance and reflects the comments received in response to the OIRA’s request for public input [see Washington Highlights, Feb. 10].  


Bipartisan House Letter Advocates for Investment in NIH

April 7, 2017

In a strong showing, a cohort of more than 200 House Republicans and Democrats March 31 joined together on a letter to the House Appropriations Committee in support of continued investment in the National Institutes of Health (NIH) in fiscal year (FY) 2018. Reps. David McKinley (R-W.Va.), Susan Davis (D-Calif.), Andre Carson (D-Ind.), and Peter King (R-N.Y.) championed the letter.


VA Research a Priority at House VA Appropriations Public Witness Hearing

March 31, 2017

he House Appropriations Subcommittee on Military Construction, Veterans Affairs and Related Agencies held a March 29 public witness hearing regarding fiscal year (FY) 2018 funding for the Department of Veterans Affairs (VA).


AAMC, Higher Ed, Senators Caution USCIS on H-1B Premium Processing Suspension

March 31, 2017

In a March 22 letter to the U.S. Citizenship and Immigration Service (USCIS), the AAMC and  four other higher education associations urged the agency to reconsider a March 3 announcement that it will temporarily suspend premium processing for all H-1B petitions for “up to 6 months”.


HHS Secretary Discusses FY 2018 Budget Blueprint before House Subcommittee

March 31, 2017

Secretary of Health and Human Service (HHS) Tom Price, MD, March 29 testified before the House Appropriations Labor-HHS Subcommittee for a hearing on the administration’s HHS fiscal year (FY) 2018 budget blueprint. 


On Government Affairs


Research Spectrum

Testimony and Correspondence